https://orcid.org/0000-0003-3145-0082
Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Liheng Li, Ke He, Siliang Chen, Wenjiang Wei, Zuofu Tian, Yinghong Tang, Chengjiang Xiao & Guoan Xiang. (2020) Circ_0001175 Promotes Hepatocellular Carcinoma Cell Proliferation and Metastasis by Regulating miR-130a-5p. OncoTargets and Therapy 13, pages 13315-13327.
Read now
Read now
Articles from other publishers (13)
Yafeng Liu, Shujun Zhang, Xiaohui Gao, Yi Ru, Xinyu Gu & Xinjun Hu. (2024) Research progress of N1-methyladenosine RNA modification in cancer. Cell Communication and Signaling 22:1.
Crossref
Crossref
Mengqiu Song, Luping Pang, Mengmeng Zhang, Yingzi Qu, Kyle Vaughn Laster & Zigang Dong. (2023) Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases. Signal Transduction and Targeted Therapy 8:1.
Crossref
Crossref
Meng Xue, Shuyi Mi, Zizhen Zhang, Hao Wang, Wenwen Chen, Wei Wei & Guochun Lou. (2022) MFAP2, upregulated by m1A methylation, promotes colorectal cancer invasiveness via CLK3. Cancer Medicine 12:7, pages 8403-8414.
Crossref
Crossref
Liujin Hou, Fan Huang, Guanghou Chen, Jian Qiu, Yuyao Liu, Hongchuan Zhao & Zhengguang Wang. (2022) Application of RNA processing factors for predicting clinical outcomes in colon cancer. Frontiers in Genetics 13.
Crossref
Crossref
Alexis C. Blackie & Daniel J. Foley. (2022) Exploring the roles of the Cdc2-like kinases in cancers. Bioorganic & Medicinal Chemistry 70, pages 116914.
Crossref
Crossref
Dalia S. El-Gamil, Ahmed K. ElHady, Po-Jen Chen, Tsong-Long Hwang, Ashraf H. Abadi, Mohammad Abdel-Halim & Matthias Engel. (2022) Development of novel conformationally restricted selective Clk1/4 inhibitors through creating an intramolecular hydrogen bond involving an imide linker. European Journal of Medicinal Chemistry 238, pages 114411.
Crossref
Crossref
Huijuan Wen, Fazhan Li, Ihtisham Bukhari, Yang Mi, Chenxu Guo, Bin Liu, Pengyuan Zheng & Simeng Liu. (2022) Comprehensive Analysis of Colorectal Cancer Immunity and Identification of Immune-Related Prognostic Targets. Disease Markers 2022, pages 1-13.
Crossref
Crossref
Bakiye Goker Bagca, Alican Kusoglu, Selin Cesmeli & Cigir Biray Avci. 2022. Unraveling the Complexities of Metastasis. Unraveling the Complexities of Metastasis
87
104
.
Peng Li Zhou, Zhengyang Wu, Wenguang Zhang, Miao Xu, Jianzhuang Ren, Qinhui Zhang, Zhanguo Sun & Xinwei Han. (2021) Circular RNA hsa_circ_0000277 sequesters miR-4766-5p to upregulate LAMA1 and promote esophageal carcinoma progression. Cell Death & Disease 12:7.
Crossref
Crossref
Mattias F. Lindberg & Laurent Meijer. (2021) Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview. International Journal of Molecular Sciences 22:11, pages 6047.
Crossref
Crossref
Paula Martín Moyano, Václav Němec & Kamil Paruch. (2020) Cdc-Like Kinases (CLKs): Biology, Chemical Probes, and Therapeutic Potential. International Journal of Molecular Sciences 21:20, pages 7549.
Crossref
Crossref
Zhihua Zheng, Yi Wen, Kechao Nie, Shuting Tang, Xu Chen, Shaoyang Lan, Jinglin Pan, Kailin Jiang, Xiaotao Jiang, Peng Liu, Yanhua Yan, Fengbin Liu, Yufeng Liu & Peiwu Li. (2020) Construction of a 13‐microRNA‐based signature and prognostic nomogram for predicting overall survival in patients with hepatocellular carcinoma. Hepatology Research 50:10, pages 1151-1163.
Crossref
Crossref
Qingxin Zhou, Meihua Lin, Xing Feng, Fei Ma, Yuekun Zhu, Xing Liu, Chao Qu, Hong Sui, Bei Sun, Anlong Zhu, Heng Zhang, He Huang, Zhi Gao, Yongxiang Zhao, Jiangyun Sun, Yuxian Bai, Junfei Jin, Xuehui Hong, Chang Zou & Zhiyong Zhang. (2020) Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolism. Journal of Experimental Medicine 217:8.
Crossref
Crossref